Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with C... ( Sub-group analysis of landmark trial ...)

HOME >> MEDICINE >> TECHNOLOGY

Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel

Date:8/31/2008

Sub-group analysis of landmark trial showed prasugrel substantially reduced risk of heart attack and stent thrombosis compared with clopidogrel among

ACS patients with diabetes

MUNICH, Germany, Aug. 31 /PRNewswire-FirstCall/ -- Patients who were diabetic and diagnosed with acute coronary syndromes (ACS) were 40 percent less likely to suffer a heart attack if they were treated with prasugrel vs. clopidogrel, according to a sub-group analysis of the TRITON-TIMI 38 trial (8.2 percent vs. 13.2 percent, P<0.001). In addition, according to this same analysis, the combined rate of cardiovascular death, non-fatal heart attack and non-fatal stroke was reduced by 30 percent in diabetes patients treated with prasugrel compared to those treated with clopidogrel (12.2 percent vs. 17.0 percent, P<0.001). In patients without diabetes, there was also improvement in outcomes with prasugrel, with the primary endpoint occurring in 9.2 percent of patients treated with prasugrel and 10.6 percent of patients treated with clopidogrel (P=0.02).

The diabetic sub-group analysis was presented today by Stephen Wiviott, M.D., Assistant Professor of Medicine at Harvard Medical School and investigator with the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham & Women's Hospital, Boston, USA, at the Congress of the European Society of Cardiology (ESC) in Munich, Germany. In addition, the manuscript was simultaneously published online in Circulation, the medical journal of the American Heart Association (AHA).

"The results observed from this sub-group analysis showed that antiplatelet therapy with prasugrel resulted in significantly greater reduction of cardiovascular events among patients with diabetes when compared to those who were treated with clopidogrel," said Wiviott.

The reduction of cardiovascular events was consistent across the sub-group of diabetes patients regardless of diabetic therapies (insulin versus no insu
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
2. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
3. TRITON-TIMI 38 Stent Analysis Favors Prasugrel
4. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
5. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
6. Study Protocols Will be Amended in Two Small Early-Phase Prasugrel Studies
7. Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients Day
8. New Data From Head-to-Head Study Confirms Once-Daily Levemir(R) is as Effective as Glargine over a 24-Hour Period in Subjects with Type 2 Diabetes
9. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
10. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
11. Variant of Mad Cow Disease May Be Transmitted by Blood Transfusions, According to Animal Study

Post Your Comments:

(Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. ... in China , today announced that it ... ended March 31, 2013, before market on Tuesday, May 28, ... May 28, 2013, at 8:00 a.m. EDT (May 28, 2013 ... financial results and provide an update on recent corporate developments. ...

(Date:5/16/2013)... , May 16, 2013 PTC Therapeutics, Inc., ... on Form S-1 with the U.S. Securities and Exchange ... of its common stock. The number of shares to ... have not been determined. (Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO ... are acting as joint book-running managers for the offering. ...

(Date:5/16/2013)... Inc. (NYSE: ALR ), a global leader in ... through the merger of rapid diagnostics and health management, has ... Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B). The dividend ... of Series B stock at the close of business on ... amount of all dividends accrued from April 1, 2013 through ...

Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2 Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3 PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2

[0] Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results [0] PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering [0] Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

... 2011 NxStage® Medical, Inc. (Nasdaq: NXTM ... announced that its Chief Executive Officer, Jeffrey H. Burbank, ... Voice of New England Innovation, 2011 All-Stars Awards. The ... New England,s innovation economy. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO) ...

... Ventana Medical Systems , Inc., (Ventana) a member of the Roche ... efficiency and throughput in today,s anatomic pathology laboratories. The new product ... annual meeting on Sept. 11, 2011, at 12:12 ... The real promise associated with the transition to ...

Cached Medicine Technology:NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award 2 NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award 3 NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award 4 Innovative Digital Pathology Solutions to be Unveiled at CAP '11 2

NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award Innovative Digital Pathology Solutions to be Unveiled at CAP '11

(Date:5/20/2013)... Chicago, IL (PRWEB) May 20, 2013 iGearUnlimited.com ... of an iPad case for students. The answers didn't surprise ... iPad from daily use and abuse, 2. Not too bulky ... and kids' backpack, 3. Built-in kick-stand that works in both ... need show as a trackable barcodes on each case, 5. ...

(Date:5/20/2013)... May 20, 2013 Milpitas, Los ... industry leader in enterprise-class information archiving, eDiscovery and ... Platform 7.0, the latest release in the MessageSolution ... of the legal discovery lifecycle. MessageSolution will exhibit ... Angeles CA. , As the first stop of ...

(Date:5/20/2013)... Can you tell a joke well? , Do ... , Would you like to be funnier as a speaker, teacher, ... funny bone is missing? , Can't think of a snappy comeback ... If this sounds like you, don't worry. Help is here. ... of humor; and even learn to tell a joke well. I ...

(Date:5/20/2013)... Olympia, WA (PRWEB) May 20, 2013 ... privacy solutions, today announced that the company’s Alliance ... TrueCrypt password management with Key Connection for ... and use cryptographically strong passwords when using TrueCrypt ... first company to offer secure password management for ...

(Date:5/19/2013)... Ga (PRWEB) May 20, 2013 California has ... country – and employers are quickly discovering that comprehensive background ... candidate for a job. Driving records can ... help reveal if that person has any DUI arrests, speeding ... more California employers are lining up to experience 4SafeDrivers.com, a ...

Breaking Medicine News(10 mins):Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 2 Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 3 Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 2 Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 3 Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 4 Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 2 Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 3 Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 4 Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 2 Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 3 Health News:4SafeDrivers.com Announces Driving Record Searches for California Employers 2

[0] New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments [0] MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo [0] Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke [0] Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords [0] 4SafeDrivers.com Announces Driving Record Searches for California Employers

... 30, 2009 at the Healthcare Travel Congress in Singapore. This is the ... an online platform to market their products and services. , ... Bangkok, ... search portal founded by medical tourism pioneer Ruben Toral, has formed ...

... acid, or vitamin B9, essential for red blood cell health ... defects, may also suppress allergic reactions and lessen the severity ... the Johns Hopkins Children,s Center. , In what is ... link between blood levels of folate the naturally occurring ...

... Generates Record $94 Million in Total Revenues for the QuarterSAN DIEGO, ... BMR ), a real estate investment trust focused on ... and financial results for the first quarter ended March 31, 2009. ... Record total revenues for the first quarter ...

... 29 /PRNewswire/ -- Traumatic brain ... brain,s structure, is common among Veterans and has been ... VA,s research related to TBI is wide-ranging. Among its ... condition; improving methods of screening and diagnosis; developing drugs ...

... chances of a relapse or a deterioration of the condition, according ... London. , The results of a major trial presented at the ... that taking a course of cladribine tablets just a few times ... over 50 per cent. And patients who took part in the ...

... ground on a revitalization project for the communityDEARBORN, Mich., ... representatives from Midwest Health Center, the City of Dearborn ... Dearborn Town Center development project - a mixed use ... space and an assisted living facility for seniors located ...

Medeguide Announces Online Marketing Partnership with Admax Plus to Promote Doctors and Treatment Packages Online Hopkins Children's study: Folic acid may help treat allergies, asthma BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results Video: Turning Hope Into Reality - Traumatic Brain Injury Research at the VA New pill to treat MS Oakwood Investment Triggers the Development of a New Landmark in Downtown East Dearborn

Inquire...

... The Genesis RMP is ideal for hospital ... for reference and pharmaceutical laboratories. It fully ... ELISA and EIA assays from different manufacturers. ... throughput of up to 600'000 tests, using ...

Qualitative EIA for SS-A, SS-B, Sm, Sm/RNP plus Scl-70 and Jo-1...

... Automation, Inc. (DAI) ENA Profile Enzyme-Linked Immunosorbent ... of antibodies in human serum to individually ... Scl-70 and Jo-1 in a single serum ... to be used as an aid in ...

Medicine Products:

BEP® III Genesis RMP ENA Profile Test Kit ENA Profile (12 test kits) Sm/RNP, Sm, Jo-1, Scl-70, SS-A, SS-B